Related Experiment Video
Updated: Dec 16, 2025

06:04
Murine Dermal Fibroblast Isolation by FACS
Published on: January 7, 2016
22.1K
Superficial CD34-Positive Fibroblastic Tumor
Oliver Foot1, Magnus Hallin1, Silvia Bagué1
1The Royal Marsden NHS Foundation Trust, London, UK.
International Journal of Surgical Pathology
|July 2, 2020
Summary
Superficial CD34-positive fibroblastic tumor (SCPFT) is a rare tumor with good prognosis. Correctly identifying SCPFT avoids misdiagnosis and overtreatment of aggressive sarcomas.
Area of Science:
- Pathology
- Oncology
- Dermatopathology
Background:
- Superficial CD34-positive fibroblastic tumor (SCPFT) is a recently identified soft tissue neoplasm.
- SCPFTs exhibit significant cellular pleomorphism, posing diagnostic challenges.
Observation:
- This entity is characterized by its superficial location and CD34-positive fibroblastic nature.
- Clinical context is crucial for accurate SCPFT diagnosis.
Findings:
- Despite marked cellular atypia, SCPFT demonstrates a favorable clinical outcome.
- Key differential diagnoses include various pleomorphic soft tissue tumors.
Implications:
- Accurate recognition of SCPFT is essential to prevent misclassification as aggressive pleomorphic sarcomas.
- Avoiding misdiagnosis can prevent unnecessary and potentially harmful overtreatment.
Keywords:
PRDM10pathologypleomorphic sarcomasoft tissue sarcomasuperficial CD34-positive fibroblastic tumorMore Related Videos
08:02Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
Published on: May 14, 2021
6.3K
06:02Isolation of CD 90+ Fibroblast/Myofibroblasts from Human Frozen Gastrointestinal Specimens
Published on: January 31, 2016
10.0K